Company profile: Synteract
1.1 - Company Overview
Company description
- Provider of full-service contract research organization (CRO) solutions focused on emerging biopharma, supporting biotech and pharmaceutical companies across all phases of drug development with multidisciplinary teams and expertise in oncology, dermatology, general medicine, infectious disease and vaccine, and neuroscience; a Syneos Health company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synteract
CordenPharma
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing services to pharmaceutical and biotechnology companies, including APIs with development, scale-up and regulatory support; non-sterile and sterile drug products (oral solids, liquids, lyophilized); synthetic lipid excipients (standard and custom); peptide development and manufacturing; and support for bioavailability, LNP formulation/manufacturing, and packaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CordenPharma company profile →
BioSim
HQ: United States
Website
- Description: Provider of solutions to enable and accelerate drug discovery at quantum accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioSim company profile →
Liberation Labs
HQ: United States
Website
- Description: Provider of industrial biotechnology infrastructure for agriculture, offering the Bio3 global precision fermentation platform, high-yield fermentation facilities, efficient fermentation processes with multiple feed capabilities and continuous sterilization, and downstream recovery using centrifugation, microfiltration and ultrafiltration to retain proteins and produce shelf-stable bioproducts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liberation Labs company profile →
ReachBio
HQ: United States
Website
- Description: Provider of biology-based research services and products to the drug development and life science research communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ReachBio company profile →
Multisorb
HQ: United States
Website
- Description: Provider of active packaging technology and sorbent solutions that protect products from moisture, oxygen, and volatiles, including desiccants, oxygen absorbers, and volatile/odor control. Offers SimulSorb and SimulOx simulation programs to predict pharmaceutical stability, APA series dispensing equipment to streamline production, and R&D services for tailored active packaging systems, testing, and evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multisorb company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synteract
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synteract
2.2 - Growth funds investing in similar companies to Synteract
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synteract
4.2 - Public trading comparable groups for Synteract
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →